Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 112, Issue 7, Pages 1241-1246
Publisher
Springer Nature
Online
2015-03-11
DOI
10.1038/bjc.2015.91
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating cell-free cancer-testis MAGE-A RNA, BORIS RNA, let-7b and miR-202 in the blood of patients with breast cancer and benign breast diseases
- (2014) S A Joosse et al. BRITISH JOURNAL OF CANCER
- Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer
- (2014) S Zanutto et al. BRITISH JOURNAL OF CANCER
- Medical therapy of gliomas
- (2014) Manmeet S. Ahluwalia et al. JOURNAL OF NEURO-ONCOLOGY
- miRNAs as Non-Invasive Biomarkers for Lung Cancer Diagnosis
- (2014) Paola Ulivi et al. MOLECULES
- MicroRNA-210 Promotes Proliferation and Invasion of Peripheral Nerve Sheath Tumor Cells Targeting EFNA3
- (2014) Zhengguang Wang et al. ONCOLOGY RESEARCH
- Elevated Expression of miR-210 Predicts Poor Survival of Cancer Patients: A Systematic Review and Meta-Analysis
- (2014) Jian Wang et al. PLoS One
- Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer
- (2014) Allen S. Ho et al. Translational Oncology
- Circulatory miR-628-5p is downregulated in prostate cancer patients
- (2014) Anvesha Srivastava et al. TUMOR BIOLOGY
- Regulation of Metastasis by microRNAs in Ovarian Cancer
- (2014) Yongchao Wang et al. Frontiers in Oncology
- Evaluation of Perfusion CT in Grading and Prognostication of High-Grade Gliomas at Diagnosis: A Pilot Study
- (2013) Jai Jai Shiva Shankar et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- HypoxamiRs and Cancer: From Biology to Targeted Therapy
- (2013) Harriet E. Gee et al. ANTIOXIDANTS & REDOX SIGNALING
- miR-210 regulates the interaction between pancreatic cancer cells and stellate cells
- (2013) Tetsuya Takikawa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis
- (2013) Silvia Pizzini et al. BMC GENOMICS
- Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer
- (2013) T Kawaguchi et al. BRITISH JOURNAL OF CANCER
- MicroRNA Targeting as a Therapeutic Strategy Against Glioma
- (2013) B. Auffinger et al. CURRENT MOLECULAR MEDICINE
- Circulating miRNAs as new blood-based biomarkers for solid cancers
- (2013) Martina Redova et al. Future Oncology
- MicroRNA-210 overexpression induces angiogenesis and neurogenesis in the normal adult mouse brain
- (2013) L Zeng et al. GENE THERAPY
- Glioblastoma and Other Malignant Gliomas
- (2013) Antonio Omuro JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genomic Basis of Aromatase Excess Syndrome: Recombination- and Replication-Mediated Rearrangements Leading toCYP19A1Overexpression
- (2013) Maki Fukami et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- MicroRNA-210 overexpression predicts poorer prognosis in glioma patients
- (2013) Nian-sheng Lai et al. JOURNAL OF CLINICAL NEUROSCIENCE
- T1–T2 dual-modal MRI of brain gliomas using PEGylated Gd-doped iron oxide nanoparticles
- (2013) Ning Xiao et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Prognostic significance of serum microRNA-210 levels in nonsmall-cell lung cancer
- (2013) Zhi-Hong Li et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Prognostic implications of serum microRNA-21 in colorectal cancer
- (2013) Pablo Menéndez et al. JOURNAL OF SURGICAL ONCOLOGY
- Serum miR-21 as a Diagnostic and Prognostic Biomarker in Colorectal Cancer
- (2013) Yuji Toiyama et al. JNCI-Journal of the National Cancer Institute
- Analysis of circulating microRNAs in adrenocortical tumors
- (2013) Diana Rita Szabó et al. LABORATORY INVESTIGATION
- Positive prognostic impact of miR-210 in non-small cell lung cancer
- (2013) Marte Eilertsen et al. LUNG CANCER
- MicroRNA in Human Glioma
- (2013) Mengfeng Li et al. Cancers
- Concomitant Activation of miR-107/PDCD10 and Hypoxamir-210/Casp8ap2 and Their Role in Cytoprotection During Ischemic Preconditioning of Stem Cells
- (2012) Ha Won Kim et al. ANTIOXIDANTS & REDOX SIGNALING
- MicroRNA-210 targets antiapoptotic Bcl-2 expression and mediates hypoxia-induced apoptosis of neuroblastoma cells
- (2012) Chung-Ching Chio et al. ARCHIVES OF TOXICOLOGY
- Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma
- (2012) An Zhao et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy
- (2012) Alexandra Nikaki et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas
- (2012) Cuihua Yang et al. INTERNATIONAL JOURNAL OF CANCER
- Hypoxia-inducible MicroRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma
- (2011) Qiao Ying et al. HEPATOLOGY
- A specific miRNA signature in the peripheral blood of glioblastoma patients
- (2011) Patrick Roth et al. JOURNAL OF NEUROCHEMISTRY
- miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity
- (2010) M-P Puisségur et al. CELL DEATH AND DIFFERENTIATION
- Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression
- (2010) Z Chen et al. ONCOGENE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now